Nitric Oxide Synthase 2, Inducible (NOS2) (N-Term) Peptide
-
- Target See all NOS2 products
- NOS2 (Nitric Oxide Synthase 2, Inducible (NOS2))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- PCATSSPVTQ DDLQYHNLSK QQNESPQPLV ETGKKSPESL VKLDATPLSS
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-NOS2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NOS2 (Nitric Oxide Synthase 2, Inducible (NOS2))
- Synonyms
- HEP-NOS Peptide, INOS Peptide, NOS Peptide, NOS2A Peptide, NOS-II Peptide, Nos-2 Peptide, Nos2a Peptide, i-NOS Peptide, iNOS Peptide, iNos Peptide, NOS2a Peptide, NOS2 Peptide, BmNOS2 Peptide, Nsl Peptide, nos2 Peptide, nitric oxide synthase 2 Peptide, nitric oxide synthase 2, inducible Peptide, inducible nitric oxide synthase Peptide, inducible nitric-oxide synthase Peptide, nanos C2HC-type zinc finger 2 Peptide, NOS2 Peptide, Nos2 Peptide, nos2 Peptide, LOC396821 Peptide, NANOS2 Peptide
- Background
-
Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17.
Alias Symbols: HEP-NOS, INOS, NOS, NOS2A
Protein Interaction Partner: ACTB,ACTN4,CAV1,NOS2,RAC1,RAC2,SLC9A3R1,SRC,CAV1,RAC1,RAC2,SLC9A3R1
Protein Size: 997 - Molecular Weight
- 110 kDa
- Gene ID
- 4843
- NCBI Accession
- NM_000625
- UniProt
- P35228
-